Clincosm LogoSign in Get a demo

Metastatic Melanoma

Showing 1 - 25 of 296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Biospecimen Collection
  • +8 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 27, 2023

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +9 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 4, 2023

Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

Active, not recruiting
  • Tumor Skin
  • +2 more
  • OBX-115
  • Orlando, Florida
  • +1 more
Sep 28, 2023

ive is Encorafenib Plus Binimetinib in Real-world and Clinical

Not yet recruiting
  • Metastatic Melanoma
  • (no location specified)
Jul 12, 2023

Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

Not yet recruiting
  • Metastatic Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 19, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Biopsy
  • +8 more
  • (no location specified)
Jun 8, 2023

Metastatic Melanoma, Immune Checkpoints Inhibitors, Gastrointestinal Microbiome (Bacterial and Viral) Trial in Ljubljana (Immune

Recruiting
  • Metastatic Melanoma
  • +3 more
  • Immune checkpoint inhibitor
  • Ljubljana, Slovenia
    Institute of Oncology Ljubljana
May 17, 2023

Generation ofArtificial Intelligence Algorithm Based on Analysis

Not yet recruiting
  • Metastatic Melanoma
  • Photo
  • (no location specified)
May 3, 2023

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)

    Completed
    • Melanoma
    • +3 more
    • Binimetinib Oral Tablet
    • Rennes, France
      Biotrial
    Mar 31, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

    Not yet recruiting
    • Metastatic Melanoma
    • Skin Cancer
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Mar 9, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Feb 28, 2023

    Metastatic Melanoma Trial in Germany (molecular tissue analysis)

    Recruiting
    • Metastatic Melanoma
    • molecular tissue analysis
    • Tuebingen, Baden-Württemberg, Germany
    • +13 more
    Feb 28, 2023

    Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

    Not yet recruiting
    • Metastatic Melanoma
    • +2 more
    • Lifileucel plus Pembrolizumab
    • Pembrolizumab with Optional Crossover Period
    • (no location specified)
    Feb 13, 2023

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester

    Not yet recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +4 more
    • Aerosol Sargramostim
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 30, 2023

    Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)

    Recruiting
    • Melanoma (Skin)
    • +4 more
    • Bloomington, Minnesota
    • +7 more
    Jan 31, 2023

    Acral Lentiginous Melanoma, CNS Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Houston (Nivolumab)

    Active, not recruiting
    • Acral Lentiginous Melanoma
    • +9 more
    • Biospecimen Collection
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +5 more
    • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
    • +3 more
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center
    Jan 31, 2023

    Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

    Recruiting
    • Metastatic Melanoma
    • Metastasis to Brain
    • Tampa, Florida
    • +1 more
    Jan 30, 2023

    Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

    Recruiting
    • Metastatic Melanoma
    • +9 more
    • TBio-4101
    • +3 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 24, 2023

    Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

    Not yet recruiting
    • Metastatic Melanoma
    • Advanced Melanoma
    • San Francisco, California
      University of California, San Francisco
    Jan 13, 2023

    Metastatic Melanoma Trial in New York (Lifileucel (LN-144))

    Recruiting
    • Metastatic Melanoma
    • Lifileucel (LN-144)
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Jan 23, 2023

    Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

    Active, not recruiting
    Has Results
    • Metastatic Melanoma
    • +22 more
    • Ipilimumab
    • +3 more
    • Birmingham, Alabama
    • +24 more
    Jan 19, 2023